estim pt challeng
lower ep estimate pt follow
challeng org sales/ep beat littl assuag pricing/gm
worri group latter come well expect
lean product though difficult env particularli us/china
gm pressur higher input cost leav re-affirmed ep
guid risk valuat look reason ntm price-to-earnings keep us hold
low-qual ep beat leav investor worri price cpg
ep beat qtr fail clear lower bar org sale beat vs street
price gm declin bp yoy mark multi-year low fan
worri around group inabl take price input cost re-infl abil
deliv re-affirmed ep guidanc
re-affirmed ep guidanc met skeptic outlook
contempl org sale growth reiter price modestli optimist
initi assum given dire input cost env commod outlook
includ increment ep headwind earn
notabl emb uncertain moder current spot price howev fx price
product gave confid maintain ep guidanc
takeaway conf call categori green shoot improv
na w/ line/slightli better vs prior ii china babi feel pressur local
co price remain competit iii price lever sheet reduct na estimate
benefit increas across region alreadi contempl though
confid iv privat label na share move around lot despit
cautiou tone capit deploy littl urgenc acceler repo despit
pullback share
lower ep input cost valuat fair given challeng
org sale estimate rel unchang lower ep reflect
continu commod inflat pt decreas also due de-rat
stapl ntm price-to-earnings trade disc hpc peer average
believ reason vs one/thre yr hist average
pt base ntm ev/ulfcf vs ntm peer average
impli price-to-earnings ev/ebitda risk em commod
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
see limit option seller buyer
signific categori overlap global
us
portfolio lead brand gener strong market
manag track record drive margin/ro
organ sale growth growth
low end compani
target long-term
em mix unlik recov near-term
model mid-single-digit growth next five year
headwind bp expans
leverag product
price target base multipl
em growth rebound pt close half gap vs prior
bp margin upsid product benefit
bp margin upsid commod turn
price target base multipl
bp top-line volum downsid
deterior em well deceler dm
bp margin downsid increas invest
bp margin downsid greater commod
price target base multipl
page
pleas see import disclosur inform page report
beat better org sale lower
sg lower tax rate partial
net sale guid edg
favor fx org sale
re-affirmed ep
maintain
posit on-line survey lead
paper initi hold difficult
environ limit stock
organ sale growth fx benefit
neutral india jv acquisit slight benefit updat
input cost inflat inflat
capital-expenditure updat
page
pleas see import disclosur inform page report
estimate actual million except product research incom expens profit incom incom equiti non-controlling incom attribut dilut continu compositionorgan sale bpsnet bpsfx bp sale bpsmargin analysisgross bpsoper bpsebitda bpstax bp
thesi chart
chart recent result well long-
chart organ sale growth
outlook base slight declin na declin
develop market growth emerg
market assum top-line growth low end
chart kmb organ sale growth em tepid
start
chart pressur growth algorithm
em contribut bp org sale growth
chart challeng environ forecast
assum kmb fx-neutral oi growth slow
chart given kmb averag growth line
margins/return stock multipl look fair
page
pleas see import disclosur inform page report
estimate organ sale growth geographydevelop average downsid forecastem organ sale organ sale growth estimate prior cycl organ sale growth algo base em/dm sensit
nielsen result period end
chart kimberly-clark four-week quarterli sale growth
nielsen xaoc jefferi note nielsen definit may differ compani defin
page
pleas see import disclosur inform page report
xaoc ckimberli clark mixlatest sale chg vs yageq sale chg vs yagavg eq price chg vs yagdollar share pt chg vs yageq share pt chg vs yag sold promo pt chg vs yag
chart kimberly-clark sale growth vs industri growth left portfolio gain market share right
page
pleas see import disclosur inform page report
factset jefferi note factset consensu estim use non-cov compani pro forma
factset jefferi note factset consensu estim use non-cov compani pro forma
factset jefferi note factset consensu estim use non-cov compani pro forma
page
pleas see import disclosur inform page report
